Endocan Corp Stock Annual Yield
| ENDO Stock | USD 0.0001 0.00 0.00% |
Endocan Corp fundamentals help investors to digest information that contributes to Endocan Corp's financial success or failures. It also enables traders to predict the movement of Endocan Pink Sheet. The fundamental analysis module provides a way to measure Endocan Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Endocan Corp pink sheet.
Endocan |
Endocan Corp Company Annual Yield Analysis
Endocan Corp's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Endocan Corp has an Annual Yield of 0.0%. This indicator is about the same for the Basic Materials average (which is currently at 0.0) sector and about the same as Specialty Chemicals (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Endocan Fundamentals
| Current Valuation | 1.87 M | |||
| Shares Outstanding | 67.89 M | |||
| Price To Earning | (0.09) X | |||
| Price To Book | 18.51 X | |||
| Net Income | (3.31 M) | |||
| Cash And Equivalents | 59 | |||
| Total Debt | 954.59 K | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (105.94 K) | |||
| Earnings Per Share | (0.12) X | |||
| Number Of Employees | 31 | |||
| Beta | 2.53 | |||
| Market Capitalization | 1.6 M | |||
| Total Asset | 359 | |||
| Retained Earnings | (32.94 M) | |||
| Working Capital | (1.49 M) | |||
| Current Liabilities | 1.49 M | |||
| Net Asset | 359 |
About Endocan Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Endocan Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Endocan Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Endocan Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Endocan Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endocan Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endocan Corp will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Endocan Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Endocan Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Endocan Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Endocan Corp to buy it.
The correlation of Endocan Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Endocan Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Endocan Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Endocan Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Endocan Pink Sheet
Endocan Corp financial ratios help investors to determine whether Endocan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endocan with respect to the benefits of owning Endocan Corp security.